[1]
M. Kaipa and D. K. Agrawal, “Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease”, ccm, vol. 10, no. 2, pp. 71–78, Apr. 2026.